PMN
ProMIS Neurosciences Inc.
Key Financials
Operating Income
$-40167308
↓ 138.7%
Net Income
$-39719147
↓ 1529.3%
EPS (Diluted)
$-22.61
↓ 20654.5%
Total Assets
$9.2M
↓ 51.4%
Total Liabilities
$10.4M
↑ 330.9%
Shareholders' Equity
$-1258592.00
↓ 107.6%
Cash & Equivalents
$6.1M
↓ 54.0%
Long-term Debt
$0.00
↓ 100.0%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | PMN |
| Company Name | ProMIS Neurosciences Inc. |
| CIK | 1374339 |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | Z4 |
| Phone | 416-847-6898 |